2 options
Guidance for industry : S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals.
Connect to full text Available online
View online- Format:
- Book
- Conference/Event
- Government document
- Conference Name:
- International Conference on Harmonisation http://viaf.org/viaf/130234339
- Language:
- English
- Subjects (All):
- Heart--Ventricles.
- Heart.
- Palpitation.
- Drugs--Testing.
- Drugs.
- Heart Ventricles.
- Medical Subjects:
- Heart Ventricles.
- Physical Description:
- 1 online resource (10 pages)
- Other Title:
- S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals
- Nonclinical evaluation of the potential for delayed ventricular repolarization (QT Interval Prolongation) by human pharmaceuticals
- Place of Publication:
- Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2005]
- Notes:
- Title from PDF title page (viewed on June 19th, 2009).
- "ICH."
- "October 2005."
- OCLC:
- 402487747
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.